SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-22-012300
Filing Date
2022-12-09
Accepted
2022-12-09 16:06:08
Documents
1
Period of Report
2022-12-08

Document Format Files

Seq Description Document Type Size
1 form4-12092022_091249.html 4  
1 form4-12092022_091249.xml 4 4012
  Complete submission text file 0001415889-22-012300.txt   5735
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Issuer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address
SCHABER CHRISTOPHER J (Reporting) CIK: 0001068029 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-14778 | Film No.: 221454817